Autologous stem cell ‐based therapy for sickle cell leg ulcer: a pilot study
In conclusion, BMMC implantation is a feasible and safe procedure, showing favourable outcomes for the treatment of SCLU, and encouraging further controlled clinical trials.
Source: British Journal of Haematology - Category: Hematology Authors: Jos é Válber L. Meneses, Vitor Fortuna, Eliane Silva Souza, Gildasio Cerqueira Daltro, Roberto Meyer, Caterina P. Minniti, Radovan Borojevic Tags: Research Paper Source Type: research
More News: Chronic Pain | Clinical Trials | Hematology | Men | Pain | Sickle Cell Anemia | Stem Cell Therapy | Stem Cells | Study